Jnana Therapeutics

Jnana Therapeutics

  • Founded: 2016
  • Location: Boston, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin1b
  • Therapy area: Phenylketonuria
  • Drug types: GEN, NPH, RAR, PED, IMM, ONC, NEU
  • Lead product: JNT-517
  • Product link: https://www.jnanatx.com/programs/
  • Funding: $107M C Nov 2022; $50M B Aug 2021; $50M A Dec 2017
  • Investors: Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Versant Ventures, Avalon Ventures, Pfizer Ventures



job board

Short description:

SLC transporter Drug Discovery

Drug notes:

5+ additional undisclosed programs RD immune-mediated & inflammatory diseases, oncology, neurology

Long description:

Jnana Therapeutics is creating therapies to treat a wide variety of diseases by uncovering and targeting unique binding sites of highly validated protein targets. Chemoproteomics is facilitating drug discovery for previously inaccessible protein targets. Jnana has built a next-generation chemoproteomics platform, RAPID, to develop small molecule medicines for any target with unprecedented speed and efficiency. This approach is enabling Jnana to address a range of challenging target classes including SLC transporters, transcription factors and signaling scaffold proteins that are significant drivers of disease. Their lead candidate, JNT-517, is targeting a SLC transporter that plays a role in PKU.


Jnana Therapeutics
Director/Sr. Director, Medicinal Chemistry
Boston, MA|55 days ago
Jnana Therapeutics
Scientist, Medicinal Chemistry
Boston, MA|55 days ago
Jnana Therapeutics
Don't see a perfect job? Apply opportunistically.
Boston, MA|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com